VEOPOZ FDA approval date

The FDA approved VEOPOZ on 18 Aug 2023.

FDA approval date
18 Aug 2023

Drug identity has not yet been verified against registry records

Also recorded as POZELIMAB-BBFG

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2023-08-18DayVEOPOZFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA761339", "applicant_as_listed_by_fda": "REGENERON PHARMACEUTICALS", "brand_names": ["VEOPOZ"], "active_ingredients": ["POZELIMAB-BBFG"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20230818", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026